Sino Biopharmaceutical Financial Overview
Sino Biopharmaceutical's market cap is currently HK$117.50B. The company's EPS TTM is HK$0.20701448732; its P/E ratio is 29.44; and it has a dividend yield of 1.37%. Sino Biopharmaceutical is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is HK$0.10. See an overview of income statement, balance sheet, and cash flow financials.
